Impact of recent genetic findings in Parkinson's disease
- PMID: 17620882
- DOI: 10.1097/WCO.0b013e3281e6692b
Impact of recent genetic findings in Parkinson's disease
Abstract
Purpose of review: Parkinson's disease is the second most common age-related neurodegenerative disorder and is characterized clinically by classical parkinsonism and pathologically by selective loss of dopaminergic neurons in the substantia nigra and Lewy bodies. Although for most classical parkinsonism the etiology is unknown, a clear genetic component has been determined in a minority. Mutations in five causative genes combined [alpha-Synuclein (SNCA), Parkin, PTEN-induced kinase 1 (PINK1), DJ-1, Leucine-rich repeat kinase 2 (LRRK2)] account for 2-3% of all cases with classical parkinsonism, often clinically indistinguishable from idiopathic Parkinson's disease.
Recent findings: The functional role of PINK1 and LRRK2 as kinases has been clearly established. Further, mutations in the ATP13A2 gene have been linked to Kufor-Rakeb syndrome (PARK9), a form of atypical parkinsonism. ATP13A2 encodes a lysosomal ATPase and shows elevated expression levels in the brains of sporadic patients, suggesting a potential role in the more common idiopathic Parkinson's disease. Finally, first promising pilot studies have been performed to identify differentially expressed genes and proteins as biomarkers for parkinsonism.
Summary: The identification of single genes and their functional characterization has enhanced our understanding of the pathogenesis of parkinsonism, has led to improvement of diagnostic tools for genetic parkinsonism, and allows for the purposeful consideration of novel therapeutic targets.
Similar articles
-
Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease.Parkinsonism Relat Disord. 2012 Jun;18(5):567-71. doi: 10.1016/j.parkreldis.2012.02.018. Epub 2012 Mar 24. Parkinsonism Relat Disord. 2012. PMID: 22445250
-
Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.Exp Neurol. 2009 Aug;218(2):235-46. doi: 10.1016/j.expneurol.2009.03.006. Epub 2009 Mar 18. Exp Neurol. 2009. PMID: 19303005 Review.
-
Emerging pathways in genetic Parkinson's disease.FEBS J. 2008 Dec;275(23):5747. doi: 10.1111/j.1742-4658.2008.06706.x. FEBS J. 2008. PMID: 19021751 No abstract available.
-
Clinical genetics of Parkinson's disease and related disorders.Parkinsonism Relat Disord. 2007;13 Suppl 3:S229-32. doi: 10.1016/S1353-8020(08)70007-5. Parkinsonism Relat Disord. 2007. PMID: 18267241 Review.
-
From genes to proteins in mendelian Parkinson's disease: an overview.Anat Rec (Hoboken). 2009 Dec;292(12):1893-901. doi: 10.1002/ar.20968. Anat Rec (Hoboken). 2009. PMID: 19943343 Review.
Cited by
-
Polyphenols Beyond Barriers: A Glimpse into the Brain.Curr Neuropharmacol. 2017;15(4):562-594. doi: 10.2174/1570159X14666161026151545. Curr Neuropharmacol. 2017. PMID: 27784225 Free PMC article. Review.
-
Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease: A Systematic Review and Meta-analysis.JAMA Netw Open. 2019 Feb 1;2(2):e187800. doi: 10.1001/jamanetworkopen.2018.7800. JAMA Netw Open. 2019. PMID: 30707228 Free PMC article.
-
Phosphorylation modulates clearance of alpha-synuclein inclusions in a yeast model of Parkinson's disease.PLoS Genet. 2014 May 8;10(5):e1004302. doi: 10.1371/journal.pgen.1004302. eCollection 2014 May. PLoS Genet. 2014. PMID: 24810576 Free PMC article.
-
iPS cell technologies: significance and applications to CNS regeneration and disease.Mol Brain. 2014 Mar 31;7:22. doi: 10.1186/1756-6606-7-22. Mol Brain. 2014. PMID: 24685317 Free PMC article. Review.
-
Exploring the Role of Ubiquitin-Proteasome System in Parkinson's Disease.Mol Neurobiol. 2022 Jul;59(7):4257-4273. doi: 10.1007/s12035-022-02851-1. Epub 2022 May 3. Mol Neurobiol. 2022. PMID: 35505049 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous